Acumen Pharmaceuticals, Inc. (ABOS) Revenue Growth
Acumen Pharmaceuticals, Inc. (ABOS) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | -34.85% |
| 2023-12-31 | -88.37% |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How ABOS compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc. | -27.50% |
| PLSE | Pulse Biosciences Inc | -50.63% |
| INO | Inovio Pharmaceuticals Inc. | -69.99% |
| ALLO | Allogene Therapeutics Inc. | -76.84% |
| XBIT | XBiotech Inc. | -78.20% |
These are five companies in the same sector as ABOS with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Acumen Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("ABOS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ABOS | $3.03 | +1.34% | 0.27M |
| 3 | ||||
| 4 | ||||
| 5 |